期刊文献+

国产阿扎司琼防治化疗所致恶心呕吐的疗效观察 被引量:3

国产阿扎司琼防治化疗所致恶心呕吐的疗效观察
下载PDF
导出
摘要 目的观察国产盐酸阿扎司琼防治化疗所致恶心、呕吐的疗效和安全性。方法对85例化疗患者采用随机对照方法,分别用国产盐酸阿扎司琼和昂丹司琼防治化疗所致的恶心、呕吐。结果国产盐酸阿扎司琼和昂丹司琼防治恶心、呕吐的总有效率(CR+PR)分别为93.0%和85.7%,两组差异无显著性(P>0.05);止呕完全缓解率(CR)分别为81.4%和61.9%,两组差异有显著性(P<0.05)。不良反应均轻微。结论国产盐酸阿扎司琼是防治化疗所致恶心、呕吐的高效、安全药物,值得推广。 Objective To explore the therapeutic effect on nausea and vomitting and side effect after chemotherapy with Azasetron Hydrechloride . Methods 85 cases of patient after chemotherapy were randomly divided into two groups: Azasetron group as drug group and Ondansetron group as control group. To prevent nausea and vomltting after chemotherapy , Azasetron were administered in Azasetron group and Ondansetron in control group. Result The total effective rate [CR and PR] was 93.0% and 85.7% respectively in the Azasetron group and the Ondansetron group .No significant differance was found between the two groups( P 〉 0.05) . The complete control rates (CR) were 81.4% and 61.9% respectively in the two groups with significant differance( P 〈 0.05 ) . The adverse effects of beth group were mild. Conclusions Azasetron is an efficient and low toxic drug in the treatment of nausea and vomltting after chemotherapy, it can be recommended widely to clinical use .
出处 《浙江临床医学》 2006年第8期802-803,共2页 Zhejiang Clinical Medical Journal
关键词 阿扎司琼 昂丹司琼 药物治疗 恶心 呕吐 Azasetron Ondansetron drug therapy nausea and vomiting
  • 相关文献

参考文献6

二级参考文献13

  • 1王金万,石廷章,张和平,孙燕.康泉预防抗肿瘤药物引起的消化道反应[J].中国新药杂志,1994,3(4):30-33. 被引量:21
  • 2[1]Beppr T,Ogawa W,Yamanaka T.Clincal evalutions of azasetron hydrodhliride: anew selective 5-HT3 receptor antagonest antiemetic profile and plasma concentration in transcatheter arterial chemoembolization using cDDP for unresectable hepatocellular carcinoma[J].Gan To Kagaku Ryoho,1998,25(8):1191-1202.
  • 3[2]Kimura E,Niimi S,Watanabe A,et al.Clinical effect of tow azasetron treatment methods against nausea and vomiting induced by anticancer drugs including cDDP[J].Gan To Kagaku Ryoho,1997,24(7):855-859.
  • 4[3]Soukop M.A comparison of low dose levels of granisetron in patients receiving high dose cisplatin[J].Eur J Cancer,1990,26(2):15-19.
  • 5Beppu T, Ogawa M, Yamanaka T, et, al. Clinical evaluation of Azasetron Hydrochloride:a new selective 5-HT3 receptor antagonist--antiemetic profile and plasma concentration in transcatheter arterial chemoembolization using CDDP for unresectable hepatocellular carcinoma[ J ].Can To Kagaku Ryoho, 1998,25 (8) :1197-1202.
  • 6Kimura E, Nilmi S, Watanabe A, et, al. Clinical effect of two azasetmn treatment methods against nausea and vomiting inducedby anticancer drugs including CDDP[ J ]. Gan To Kagaku Ryoho,1997,24(7) : 855-859.
  • 7Kimura E, Niimi S, Watanabe A, et, al. Study on clinical effect of a continuous intravenous infusion of azasetron against nausea and vomiting induced by anticancer drugs including CDDP[J]. Can To Kagalm Ryoho,1996,2,3(4) : 477-481.
  • 8胡文能 王庆德.胃复安的临床应用及副作用[J].临床荟萃,1996,12(1):36-36.
  • 9王雅杰,杨红斌,傅强.国产盐酸阿扎司琼注射液止吐疗效观察[J].第二军医大学学报,2002,23(4):377-377. 被引量:8
  • 10刘嵘,王建华,周康荣,颜志平,程洁敏,钱晟,刘清欣,龚高全.肝动脉化疗栓塞治疗原发性肝癌中碘油沉积良好患者疗效观察[J].介入放射学杂志,2001,10(4):212-214. 被引量:42

共引文献25

同被引文献32

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部